ArticleApplied health economics and health policy2015
Improving Cross-Sector Comparisons: Going Beyond the Health-Related QALY.
Article in Applied health economics and health policy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Discrete Choice Experiments in Health State Valuation: A Systematic Review of Progress and New Trends.Applied health economics and health policy · 2023Pooled it
- Group-based trajectory modelling of multiple health outcomes in a cost-consequence framework: a randomized controlled trial of a remote person-centred care intervention for people with common mental disorders in Sweden.Journal of patient-reported outcomes · 2026Trial
- Exploring subjective constructions of quality of life in patients, carers and the healthy general public: a Q-methodological study.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2025Article
- Design and selection of items for a new health-related quality of life instrument with infertility patients (Infertility-QoL): a national multicenter, four-phase, mixed-methods study.Health and quality of life outcomes · 2025Article
- Are Economic Evaluations of Task Shifting Too Narrow in Focus? A Rapid Review.PharmacoEconomics · 2025Review
- A framework for extending the health-related quality adjusted life year by combining instruments.Health and quality of life outcomes · 2025Article
- A framework for quantifying the multisectoral burden of animal disease to support decision making.Frontiers in veterinary science · 2025Review
- On spillovers in economic evaluations: definition, mapping review and research agenda.The European journal of health economics : HEPAC : health economics in prevention and care · 2024Review
- Can items derived from international literature be used in national quality of life instruments? A qualitative study conceptualising the EQ-HWB in China.Journal of patient-reported outcomes · 2024Article
- Obtaining preference scores for an abbreviated self-completion version of the Teen-Addiction Severity Index (ASC T-ASI) to value therapy outcomes of systemic family interventions: a discrete choice experiment.The European journal of health economics : HEPAC : health economics in prevention and care · 2024Article
- Health-related quality of life and subjective well-being among children aged 9-12 years in Shandong Province, China.Health and quality of life outcomes · 2024Article
- Content validity of the EQ-HWB and EQ-HWB-S in a sample of Italian patients, informal caregivers and members of the general public.Journal of patient-reported outcomes · 2024Article
- Reimagining the relationship between economics and health- WHO 'Health for all' provisions.Cost effectiveness and resource allocation : C/E · 2024Article
- Estimating loss in capability wellbeing in the first year of the COVID-19 pandemic: a cross-sectional study of the general adult population in the UK, Australia and the Netherlands.The European journal of health economics : HEPAC : health economics in prevention and care · 2023Article
- Expanding health technology assessment towards broader value: Ireland as a case study.International journal of technology assessment in health care · 2023Review
- The Broader Opportunity Costs in the Broader Cost-Effectiveness Analysis Framework.Applied health economics and health policy · 2023Article
- Unmet Parenthood Goals, Health-Related Quality of Life and Apparent Irrationality: Understanding the Value of Treatments for Infertility.PharmacoEconomics - open · 2023Article
- Measuring the cost-effectiveness of treatments for people with multiple sclerosis: Beyond quality-adjusted life-years.Multiple sclerosis (Houndmills, Basingstoke, England) · 2022Review
- NICE and the EQ-5D-5L: Ten Years Trouble.PharmacoEconomics - open · 2022Article
- The Utility of Economic Measures to Quantify the Burden of Tinnitus in Affected Individuals: A Scoping Review.PharmacoEconomics - open · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The quality-adjusted life-year (QALY) has become a widely used measure of health outcomes for use in informing decision making in health technology assessment. However, there is growing recognition of outcomes beyond health within the health sector and in related sectors such as social care and public health. This paper presents the advantages and disadvantages of ten possible approaches covering extending the health-related QALY and using well-being and monetary-based methods, in order to address the problem of using multiple outcome measures to inform resource allocation within and between sectors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.